SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-007808
Filing Date
2021-03-09
Accepted
2021-03-09 17:22:44
Documents
3
Period of Report
2021-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10021424_8k.htm 8-K 18452
2 EXHIBIT 99.1 brhc10021424_ex99-1.htm EX-99.1 284931
3 image0.jpg GRAPHIC 49632
  Complete submission text file 0001140361-21-007808.txt   373005
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 21726982
SIC: 2834 Pharmaceutical Preparations